ADMA Biologics (ADMA) is scheduled to report first-quarter 2025 results on May 7, after market close.The Zacks Consensus Estimate for sales and earnings is pegged at $119.1 million and 16 cents per share, respectively. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)Earnings estimate for 2025 has increased to 71 cents from 69 cents per share over the past 60 days, and the same for 2026 has improved to 93 cents from 87 cents.Image Source: Zacks Investment ResearchADMA’s Earnings Surp ...